| Literature DB >> 35568737 |
Justin Moore1, Nathalie Zaidman2, Isabel Fernandes Arroteia3, Geoffrey Appelboom4, Sami Barrit5, Sébastien Carlot6, Viviane De Maertelaer7, Sergio Hassid6, Olivier De Witte5, Julien Spitaels8.
Abstract
Various surgical methods to prevent postoperative cerebrospinal fluid (CSF) leaks during transsphenoidal surgery have been reported. However, comparative studies are scarce. We aimed to compare the efficacy of a fibrin-coated collagen fleece (TachoSil) versus a dural sealant (DuraSeal) to prevent postoperative CSF leakage. We perform a retrospective study comparing two methods of sellar closure during endoscopic endonasal transsphenoidal surgery (EETS) for pituitary adenoma resection: TachoSil patching versus DuraSeal packing. Data concerning diagnosis, reconstruction technique, and surgical outcomes were analyzed. The primary endpoint was postoperative CSF leak rate. We reviewed 198 consecutive patients who underwent 219 EETS for pituitary adenoma from February 2007 and July 2018. Intraoperative CSF leak occurred in 47 cases (21.5%). A total of 33 postoperative CSF leaks were observed (15.1%). A reduction of postoperative CSF leaks in the TachoSil application group compared to the conventional technique using Duraseal was observed (7.7% and 18.2%, respectively; p = 0.062; Pearson exact test) although non-statistically significant. Two patients required lumbar drainage, and no revision repair was necessary to treat postoperative CSF rhinorrhea in Tachosil group. Fibrin-coated collagen fleece patching may be a valuable method to prevent postoperative cerebrospinal fluid (CSF) leaks during EETS for pituitary adenoma resection.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35568737 PMCID: PMC9107464 DOI: 10.1038/s41598-022-12059-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Demographics variables.
| Demographics variables | Tachosil application group | DuraSeal packing group | p value |
|---|---|---|---|
| Number of patients | 61 | 137 | |
| Male (%) | 29 (47.5%) | 68 (49.6%) | 0.878 |
| Mean age, year ± SD | 50.7 ± 14.6 | 50.7 ± 14.6 | 1.000 |
| Nonfunctioning adenomas | 30 (49.2%) | 72 (52.6%) | 0.760 |
| Functioning adenomas | 23 (37.7%) | 50 (36.5%) | 0.875 |
| Apoplexies | 0 (0%) | 4 (2.9%) | 0.314 |
| Unknown diagnoses (loss of sample, hemorrhage, insufficient sampling) | 8 (13.1%) | 11 (8.1%) | 0.302 |
Preoperative characteristics of adenomas.
| Preoperative variable | Tachosil application group | DuraSeal packing group | p value |
|---|---|---|---|
| Number of surgery | 65 | 154 | |
| Macroadenoma | 56 (86.2%) | 129 (83.8%) | 0.690 |
| Mean size, mm ± SD | 20.9 ± 8.5 | 21.9 ± 10.6 | 0.441 |
| I | 9 (13.8%) | 25 (16.2%) | 0.690 |
| II | 52 (80%) | 104 (67.5%) | 0.730 |
| III | 1 (1.5%) | 12 (7.8%) | 0.115 |
| IV | 3 (4.6%) | 13 (8.4%) | 0.404 |
| 0 | 12 (18.5%) | 54 (35.1%) | 0.016 |
| A | 26 (40%) | 39 (25.3%) | 0.036 |
| B | 14 (21.5%) | 28 (18.2%) | 0.577 |
| C | 13 (20%) | 33 (21.4%) | 0.858 |
| Previous surgery | 12 (18.5%) | 41 (26.6%) | 0.153 |
Complications related with transsphenoidal approach surgery according to closure method.
| Surgical variable | Tachosil application group | DuraSeal packing group | |
|---|---|---|---|
| 12/65 (18.5%) | 35/154 (22.7%) | p = 0.590 | |
| Low flow | 10/12 (83.3%) | 21/35 (60%) | |
| High flow | 2/12 (16.7%) | 14/35 (40%) | p = 0.176 |
| Postoperative CSF rhinorrhea | 5/65 (7.7%) | 28/154 (18.2%) | p = 0.062 |
| Diamox | 5/65 (7.7%) | 25/154 (16.2%) | p = 0.131 |
| Postoperative lumbar drainage | 2/65 (3.1%) | 11/154 (7.1%) | p = 0.353 |
| Revision repair | 0/65 (0%) | 4/154 (2.6%) | p = 0.321 |
| Meningitis | 1/65 (1.5%) | 4/154 (2.6%) | p = 1.000 |
| Death | 0/65 (0%) | 2/154 (1.3%) | p = 1.000 |
| Mean length of hospital stay, days ± SD | 7.1 ± 4.1 | 7.8 ± 4.6 | p = 0.280 |
CSF cerebrospinal fluid.
Summary of studies using Tachosil for sellar closure during transsphenoidal surgery.
| Closure technique | Approach | Material | N patient exposed | Intraoperative CSF leak | PO CSF leak | LD | Surgery | Remark |
|---|---|---|---|---|---|---|---|---|
| TACHOSIL | EETS (present sudy) | One layer Tachosil + Tissucol | 65 | 12 | 7.7% (5/65) | 2 | 0 | Cost Virus transmission + easily removed in revision repair + immunologically well tolerated + hemostasis + lower postoperative infection |
| MTS ± endoscope[ | Sandwich technique | 101 | 18 | 1.9% (2/101) | 0 | 0 | ||
| MTS[ | Sandwich technique | 19 | 19 | 5.3% (1/19) | 0 | 0 | ||
| MTS − EETS[ | Surgicel + Tachosil | 29 | 29 | 0% (0/29) | 0 | 0 |
N number, PO postoperative, LD lumbar drainage, EETS endonasal endoscopic transphenoidal surgery, MTS microscopic transsphenoidal surgery.
Summary of various techniques for sellar closure during transsphenoidal surgery.
| Closure technique | Approach | Material | N patient exposed | Intraoperative CSF leak | PO CSF leak | LD | Surgery | Remark |
|---|---|---|---|---|---|---|---|---|
| Free autologous graft | MTS[ | Muscle + septal cartilage | 23 | 23 | 0% (0/23) | 0 | 0 | + Totally compatible + Free of charge − ↑ operative time − Separate incision (complications) − Additional discomfort − MRI interference − Inadequate packing: optic chiasm compression, ↑ Arachnoid tearing |
| MTS − EETS[ | Fat + autologous bone | 29 | 29 | 10% (3/29) | 2 | 1 repair | ||
| EETS[ | Fat graft + artificial dura | 55 | 55 | 7.3% (4/55) | 4 | 2 repairs | ||
| EETS − METS ± endoscope[ | Fat graft + fibrin glue | 54 | 15 | 9.3% (5/54) | 22 | – | ||
| MSTS − EETS − hybrid[ | Fat | 87 | 7 | 9.2% (8/87) | – | 2 repairs | ||
| EETS[ | Fat + autologous bone/cartilage + glue | 235 | – | 1.7% (4/235) | 4 | 1 repair + LD | ||
| EETS[ | Collagen dural graft + nasal cavity floor free mucosal graft + oxidized cellulose + polyethylene glue + Bioresorbable packing | 50 | 20 | 0 (0/50) | 0 | 0 | ||
| Cadaveric graft | ETTS[ | Fat + cadaveric fascia lata + Fibrin glue | 16 | 16 | 0% (0/16) | 9 | 0 | + No separate incision − MRI interference − Not support healing as living tissue |
| MSTS − EETS − hybrid[ | Alloderm | 163 | 8 | 5.5% (9/163) | – | 2 repairs | ||
| MTS − EETS[ | Alloderm + cartilage/bone autograft + fibrin glue | 13 | 5 | 7.6 (1/13) | 1 | 0 | ||
| Pediculized flap | 3 EETS[ | Various pediculized flap (144 NSF) | 151 | 151 | 3.3% (5/151) | + Rapid/effective integration − ↑ operative time − ↑ healing period − Nasal complaints (crusting) | ||
| Fascia graft + fat graft + NSF | 31 | 31 | 6.4% (2/31) | 2 | 1 repair | |||
| Posterior NSF (If leak: Alloderm + NSF ± fat graft ± LD) | 43 | 21 | 2.3% (1/43) | 2 | 1 repair + LD | + Small flap − Limitation of covered areas − LD complications | ||
| Fibrin sealant | 5 EETS[ | Gelatin sponge | 28 | 28 | 3.6% (1/28) | 0 | 1 VPS | + Reabsorbed − Virus transmission -bovine spongiform encephalitis − animal derivatives against patient wishes |
| Collagen fleece | 29 | 29 | 6.9% (2/29) | 6 | 0 | |||
| – | 40 | 40 | 0% (0/40) | 0 | 0 | |||
| Collagen foil | 15 | 9 | 6.7% (1/15) | 0 | 1 repair | |||
| Different combinations: fat − spongostan − floseal | 16 | – | 12.5% (2/16) | – | – | |||
| Duraseal | EETS[ | Different combinations: fat − spongostan − floseal | 180 | – | 5.6% (10/180) | – | – | + Synthetic: no disease transmission + Immunologically well tolerated + Reabsorbed |
| Graded repair method | EETS[ | Stage I: Surgicel + Gelfoam Stage II: fat + fascia + same as Stage I Stage III: same as Stage II + surgical glue ± LD | 240 | 107 | 0.8% | 1 | 1 | LD complications |
| EETS[ | Grade 0: collagen sponge Grade 1: collagen sponge + titanium mesh buttress Grade 2: fat grafts + same as grade 1 Grade 3: same as Grade 2 + LD | 668 | 380 | 2.5% (17/668) | 6 | 11 | LD complications |
N number, PO postoperative, LD lumbar drainage, MTS microscopic transsphenoidal surgery, EETS endonasal endoscopic transphenoidal surgery, NSF nasoseptal flap, VPS ventriculoperitoneal shunt, + advantage, − disavantages.